In last trading session, Pulmatrix, Inc. (NASDAQ:PULM) saw 674,837 shares changing hands with its beta currently measuring 1.81. Company’s recent per share price level of $1.83 trading at $0 or -2.66% at recent trade assigns it a market valuation of $46.77 Million. That current price of PULM’s stock is at a discount of -12.3% from its 52-week high price of $2.055 and is indicating a premium of 66.67% from its 52-week low price of $0.61. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 901.77 Million shares which gives us an average trading volume of 1.15 Million if we extend that period to 3-months.

For Pulmatrix, Inc. (PULM), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 0. Splitting up the data highlights that, out of 1 analysts covering the stock, none rated the stock as a Sell while none recommended an Overweight rating for the stock. None suggested the stock as a Hold whereas 1 see the stock as a Buy. None analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -$0.38 in the current quarter.

Pulmatrix, Inc. (NASDAQ:PULM) trade information

In the face of being in the red today for losing -6.88%, in the last five days PULM remained trading in the green while hitting it’s week-highest on Tuesday, Jun 23 when the stock touched $2.02 price level, adding 12.38% to its value on the day. Pulmatrix, Inc.’s shares saw a change of 105.81% in year-to-date performance and have moved -2.21% in past 5-day. Pulmatrix, Inc. (NASDAQ:PULM) showed a performance of -4.32% in past 30-days. Number of shares sold short was 1.37 Million shares which calculate 1.19 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of $10 to the stock, which implies a rise of 446.45% to its current value. Analysts have been projecting $10 as a low price target for the stock while placing it at a high target of $10. It follows that stock’s current price would jump +446.45% in reaching the projected high whereas dropping to the targeted low would mean a loss of 446.45% for stock’s current value.

Pulmatrix, Inc. (PULM) estimates and forecasts

Statistics highlight that Pulmatrix, Inc. is scoring comparatively higher than the scores of other players of the relevant industry. The company added +122.64% of value to its shares in past 6 months, showing an annual growth rate of 68.75% while that of industry is 9.2. Apart from that, the company came raising its revenue forecast for fiscal year 2020. The company is estimating its revenue growth to increase by 7.3% in the current quarter and calculating -122.2% decline in the next quarter. This year revenue growth is estimated to drop -65.1% from the last financial year’s standing.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 48.7% during past 5 years. In 2020, company’s earnings growth rate is likely to be around 75.3% while estimates for its earnings growth in next 5 years are of 0%